Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shenlian extract protects against ultrafine particulate matter-aggravated myocardial ischemic injury by inhibiting inflammation response via the activation of NLRP3 inflammasomes. | Environ Toxicol | 2021 | 33729688 | PubTator, text mining | PubMed |
| Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA. | Infect Agent Cancer | 2021 | 33726794 | PubTator, text mining | PubMed |
| Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma. | Front Cell Dev Biol | 2021 | 33718368 | PubTator, text mining | PubMed |
| Bub1 kinase in the regulation of mitosis. | Anim Cells Syst (Seoul) | 2021 | 33717411 | PubTator, text mining | PubMed |
| Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis. | Cancer Med | 2021 | 33713047 | PubTator, text mining | PubMed |
| Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis. | AIMS Neurosci | 2021 | 33709028 | PubTator, text mining | PubMed |
| Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis. | Gland Surg | 2021 | 33708561 | PubTator, text mining | PubMed |
| Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis. | Biomed Res Int | 2021 | 33688500 | PubTator, text mining | PubMed |
| FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma. | Aging (Albany NY) | 2021 | 33686947 | PubTator, text mining | PubMed |
| Molecular characterization of long-term survivors of hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 33686022 | PubTator, text mining | PubMed |
| Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer. | Bioengineered | 2021 | 33682613 | PubTator, text mining | PubMed |
| Spotlight on USP4: Structure, Function, and Regulation. | Front Cell Dev Biol | 2021 | 33681193 | PubTator, text mining | PubMed |
| Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature. | J Pers Med | 2021 | 33672900 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Caco-2 Cells upon the Exposure of Mycotoxin Deoxynivalenol and Its Acetylated Derivatives. | Toxins (Basel) | 2021 | 33671637 | PubTator, text mining | PubMed |
| Genes Regulating Spermatogenesis and Sperm Function Associated With Rare Disorders. | Front Cell Dev Biol | 2021 | 33665191 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. | BMC Cancer | 2021 | 33648465 | PubTator, text mining | PubMed |
| Screening and Identification of Key Common and Specific Genes and Their Prognostic Roles in Different Molecular Subtypes of Breast Cancer. | Front Mol Biosci | 2021 | 33644115 | PubTator, text mining | PubMed |
| Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know? | Endocr Pathol | 2021 | 33641055 | PubTator, text mining | PubMed |
| Global Gene Expression of Cultured Human Dermal Fibroblasts: Focus on Cell Cycle and Proliferation Status in Improving the Condition of Face Skin. | Int J Med Sci | 2021 | 33628110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=58